India · Delayed Price · Currency is INR Glenmark Pharmaceuticals Statistics
Total Valuation
BOM:532296 has a market cap or net worth of INR 542.93 billion. The enterprise value is 550.60 billion.
| Market Cap | 542.93B |
| Enterprise Value | 550.60B |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Sep 13, 2024 |
Share Statistics
| Current Share Class | 282.20M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -2.85% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 142.26M |
Valuation Ratios
The trailing PE ratio is 72.03 and the forward PE ratio is 29.04.
| PE Ratio | 72.03 |
| Forward PE | 29.04 |
| PS Ratio | 4.03 |
| PB Ratio | 6.14 |
| P/TBV Ratio | 7.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 73.05 |
| EV / Sales | 4.09 |
| EV / EBITDA | 22.28 |
| EV / EBIT | 28.10 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.00 |
| Debt / FCF | n/a |
| Interest Coverage | 8.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 12.01% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 8.98M |
| Profits Per Employee | 502,836 |
| Employee Count | 14,989 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532296 has paid 2.79 billion in taxes.
| Income Tax | 2.79B |
| Effective Tax Rate | 26.98% |
Stock Price Statistics
The stock price has increased by +12.70% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +12.70% |
| 50-Day Moving Average | 1,974.26 |
| 200-Day Moving Average | 1,601.51 |
| Relative Strength Index (RSI) | 39.24 |
| Average Volume (20 Days) | 22,322 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532296 had revenue of INR 134.56 billion and earned 7.54 billion in profits. Earnings per share was 26.70.
| Revenue | 134.56B |
| Gross Profit | 91.97B |
| Operating Income | 19.59B |
| Pretax Income | 10.32B |
| Net Income | 7.54B |
| EBITDA | 24.71B |
| EBIT | 19.59B |
| Earnings Per Share (EPS) | 26.70 |
Balance Sheet
The company has 17.05 billion in cash and 24.73 billion in debt, giving a net cash position of -7.67 billion.
| Cash & Cash Equivalents | 17.05B |
| Total Debt | 24.73B |
| Net Cash | -7.67B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 88.49B |
| Book Value Per Share | 304.50 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 68.35%, with operating and profit margins of 14.56% and 5.60%.
| Gross Margin | 68.35% |
| Operating Margin | 14.56% |
| Pretax Margin | 7.67% |
| Profit Margin | 5.60% |
| EBITDA Margin | 18.36% |
| EBIT Margin | 14.56% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.13%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 0.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.36% |
| Buyback Yield | -0.06% |
| Shareholder Yield | 0.06% |
| Earnings Yield | 1.39% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.
| Last Split Date | Sep 10, 2007 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |